obinutuzumab April 12, 2017 obinutuzumab Trade Name Gazyva Orphan Indication Splenic marginal zone lymphoma USA Market Approval USA USA Designation Date 2017-08-17 00:00:00 Sponsor Genentech, Inc.;1 DNA Way, MS 241B;South San Francisco, California, 94080
